Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Sabine D. Allard, Brenda De Keersmaecker, Anna L. de Goede, Esther J. Verschuren, Jeanette Koetsveld, Mariska L. Reedijk, Carolien Wylock, Annelies V. De Bel, Judith Vandeloo, Frank Pistoor, Carlo Heirman, Walter E.P. Beyer, Paul H.C. Eilers, Jurgen Corthals, Iman Padmos, Kris Thielemans, Albert D.M.E. Osterhaus, Patrick Lacor, Marchina E. van der Ende, Joeri L. AertsCarel A. van Baalen, Rob A. Gruters

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)88-89
Number of pages2
JournalClinical Immunology
Volume150
Issue number1
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • hiv-1

Cite this